Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-137791
Filing Date
2024-12-18
Accepted
2024-12-18 14:10:11
Documents
1
Period of Report
2024-12-18

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 9075
  Complete submission text file 0000950170-24-137791.txt   10572
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent, Inc. (Issuer) CIK: 0001596783 (see all company filings)

IRS No.: 208737688 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CATALENT, INC. 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address
Gennadios Aristippos (Reporting) CIK: 0001612357 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36587 | Film No.: 241558603